Healthcare leaders aren’t confused about whether AI introduces risk. That part is obvious.
What they’re struggling with is a more operational question:
Which AI risks actually create legal exposure, for whom, and under what conditions?
If you can answer that consistently, AI governance becomes a manageable system. If you can’t, governance devolves into a debate club—where every tool is labeled “high risk,” every review is bespoke, and every approval decision feels impossible to defend six months later.
The core idea behind effective AI governance is straightforward: legal liability is downstream of technical risk—but it’s shaped by context. What kind of AI is it? Who uses it? What decisions does it influence? And how tightly is it woven into real workflows?
That context-first framing isn’t new. It’s exactly how mature risk-management frameworks approach AI. The NIST AI Risk Management Framework explicitly rejects checklist-style compliance and instead organizes AI risk around understanding context (MAP), measuring and testing systems (MEASURE), establishing governance (GOVERN), and managing mitigations over time (MANAGE)1.
What’s missing in many healthcare AI programs is the bridge between that risk framing and what legal, compliance, patient safety, and insurers ultimately care about: liability.
This post proposes that bridge:
map AI technology → use case and end user → risk domains → legal liabilities → protections—in a way that aligns with published frameworks and real enforcement dynamics, not theoretical AI ethics.
Treating “AI” as a single category is like regulating “vehicles” without distinguishing between bicycles, sedans, and autonomous semi-trucks. Technically accurate. Operationally useless.
Regulators and standards bodies don’t make that mistake. NIST requires organizations to map a system’s purpose, environment, and impacts before attempting to measure or manage risk2.
ISO takes the same position from a management-system perspective. ISO/IEC 42001, the international AI management system standard, requires organizations to establish lifecycle governance, accountability, and continuous improvement—not one-time approval gates3.
Healthcare-specific guidance reinforces this further. The FDA’s Good Machine Learning Practice (GMLP) principles emphasize lifecycle controls—data quality, validation, monitoring—because in medical contexts, conditions of use often matter as much as model architecture4,5.
In other words: you don’t manage AI risk in the abstract. You manage AI risk for a specific technology, in a specific workflow, with specific decision authority, affecting specific patients or populations.
That distinction becomes even more important when we talk about legal liability—because liability is rarely triggered by “the model.” It’s triggered by a harm event, a rights violation, a billing failure, or a security incident.
Different AI systems fail in different ways.
These differences aren’t academic. They’re legal accelerants.
As AI systems move from informing decisions → generating content that becomes the record → taking actions, organizations face increasing difficulty in:
“Show your work” is no longer a metaphor. It is increasingly the standard expectation across clinical quality, billing integrity, and compliance regimes.
Defining a universal healthcare AI use-case taxonomy is notoriously hard, because “use case” depends on perspective—vendor marketing, clinician workflow, IT architecture, or compliance posture.
In practice, the most reliable organizing principle is end user—who holds decision authority.
From there, use cases naturally cluster into a small number of parent domains:
This framing aligns with how governance committees are actually structured—and with guidance from professional bodies like the American Medical Association, which emphasizes transparency, accountability, and responsibility for AI used in clinical care6.
Why this matters legally is simple: liability tends to attach to the party with the duty, authority, and ability to prevent harm. End user is often the clearest signal for where that duty lives.
Once technology type and end user are defined, AI risks can be evaluated across stable domains, many of which map directly to NIST’s trustworthiness characteristics.
Common domains include:
The mistake is treating these as a checklist. NIST is explicit that the framework is context-dependent, not prescriptive7.
In liability terms, some domains become load-bearing:
Generative AI dramatically increases risk in that last category.
AI risk in healthcare consistently maps to five categories of legal exposure:
If AI influences diagnosis, triage, or treatment, harm can trigger malpractice claims. Organizations also face corporate negligence theories if they failed to vet, train, monitor, or constrain the system.
HHS OCR has made clear that ACA §1557 applies to patient care decision support tools, including AI. Covered entities must make reasonable efforts to identify and mitigate discrimination risks8.
AI expands the PHI attack surface. HIPAA obligations—including security risk analysis—still apply, regardless of whether data flows through a model9.
When AI outputs enter documentation or coding workflows, organizations assume integrity risk. CMS documentation rules have not changed—AI just makes errors faster and harder to detect10.
Misrepresentations, silent model updates, weak audit rights, and unclear responsibility allocation can all create exposure—often before statutory liability ever triggers.
Generative AI commonly appears in:
The load-bearing risk domains are predictable:
The resulting liabilities—malpractice, corporate negligence, billing risk, and §1557 exposure—are equally predictable.
The point isn’t that generative AI is dangerous. The point is that its risk profile is legible—and therefore governable—if you map it correctly.
Organizations often try to manage AI liability with contract templates. That fails because contracts only matter if they’re aligned to real risk.
Every major framework—NIST, FDA/IMDRF, ISO 42001—assumes governance is lifecycle-based and evidence-driven11,12,13.
A defensible protection strategy has two pillars:
Vendor-facing controls
Implementer-side controls
This is how organizations create evidence of reasonableness—the currency regulators, auditors, and courts actually care about.
Once this mapping exists, AI governance becomes pattern recognition rather than debate:
That’s what mature AI risk management looks like: not fear, not guesswork, but repeatable, defensible decisions at scale.
